Abstract
Licensing of individual pharmaceuticals has been used for many years as a mean of securing efficacy and safety of such products. During the last ten years a number of countries have introduced legislation in the field of radiopharmaceuticals (radioactive material intended for use in medical diagnosis or therapy). In order to obtain an up-to-date survey of the situation in European countries on the requirements for a licensing of radiopharmaceuticals letters were sent to authorities and individuals in all European countries. The following very short summary was written based on the replies received, and on information supplied by individuals. In the annex a list of adresses of relevant national authorities is given. In most countries regulations with the purpose of radiation protection with regard to workers and patients have been in force for many years. Such regulations are not reviewed here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Kristensen, K. (1984). Licensing of Radiopharmaceuticals in European Countries 1982. In: Kristensen, K., Nørbygaard, E. (eds) Safety and efficacy of radiopharmaceuticals. Developments in Nuclear Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6753-3_23
Download citation
DOI: https://doi.org/10.1007/978-94-009-6753-3_23
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6755-7
Online ISBN: 978-94-009-6753-3
eBook Packages: Springer Book Archive